Recombinetics

Recombinetics, Inc. is a biotechnology company specializing in gene editing technologies aimed at enhancing human health and improving animal agriculture. Founded in 2008 and based in Eagan, Minnesota, the company develops gene-edited pig models for use in human cardiac therapeutics testing, as well as TALENs, tools designed for gene editing in large animals. These technologies facilitate biomedical research, regenerative medicine, and promote better animal welfare and productivity through precision breeding. By manipulating DNA to add and activate genes, Recombinetics addresses various health challenges and aims to advance both human medical applications and livestock productivity, thereby contributing to the fields of human health and animal agriculture on a global scale.

Peter Hajas

Chairman

1 past transactions

Makana Therapeutics

Acquisition in 2020
Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of cells, tissues and organs from these animals possible. Makana’s focus on simplified genetics, optimized pig cloning techniques and careful patient selection is expected to streamline product development and result in safer more efficacious products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.